Search research articles
Contact Us
Filters
Showing results (961-970 of 7,076) with videos related to
Page
of 708
Sort By:
Drugs
|
January 1, 1993
Epirubicin. Clinical pharmacology and dose-effect relationship
J Robert
Drugs
|
January 1, 1993
Preoperative chemotherapy in operable breast cancer. The influence of timing FEC in relation to surgery
C J van de Velde
Drugs
|
January 1, 1993
Premenopausal patients with node-positive resectable breast cancer. Preliminary results of a randomised trial comparing 3 adjuvant regimens: FEC 50 x 6 cycles vs FEC 50 x 3 cycles vs FEC 75 x 3 cycles. The French Adjuvant Study Group
P Fumoleau, Y Devaux, M L Vo Van, et al.
Drugs
|
September 1, 1993
Current status of dopamine agonists in Parkinson's disease management
J L Montastruc, O Rascol, J M Senard
Drugs
|
September 1, 1993
Choosing the right analgesic. A guide to selection
Timothy G Bushnell, Douglas M Justins
Drugs
|
September 1, 1993
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer
Ruth Whittington, Diana Faulds
Drugs
|
October 28, 2016
Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Gillian M Keating
Drugs
|
October 28, 2016
The Impact of Shortages on Medication Prices: Implications for Shortage Prevention
Michail Alevizakos, Marios Detsis, Christos A Grigoras, et al.
Drugs
|
February 12, 2004
The role of proton pump inhibitors in gastro-oesophageal reflux disease
Roy Dekel, Chad Morse, Ronnie Fass
Drugs
|
November 2, 2004
Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system
André J Scheen
Page
of 708
Search research articles
Search
Showing results (961-970 of 7,076) with videos related to
Sort By:
Page
of 708
Drugs
|
January 1, 1993
Epirubicin. Clinical pharmacology and dose-effect relationship
J Robert
Drugs
|
January 1, 1993
Preoperative chemotherapy in operable breast cancer. The influence of timing FEC in relation to surgery
C J van de Velde
Drugs
|
January 1, 1993
Premenopausal patients with node-positive resectable breast cancer. Preliminary results of a randomised trial comparing 3 adjuvant regimens: FEC 50 x 6 cycles vs FEC 50 x 3 cycles vs FEC 75 x 3 cycles. The French Adjuvant Study Group
P Fumoleau, Y Devaux, M L Vo Van, et al.
Drugs
|
September 1, 1993
Current status of dopamine agonists in Parkinson's disease management
J L Montastruc, O Rascol, J M Senard
Drugs
|
September 1, 1993
Choosing the right analgesic. A guide to selection
Timothy G Bushnell, Douglas M Justins
Drugs
|
September 1, 1993
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer
Ruth Whittington, Diana Faulds
Drugs
|
October 28, 2016
Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Gillian M Keating
Drugs
|
October 28, 2016
The Impact of Shortages on Medication Prices: Implications for Shortage Prevention
Michail Alevizakos, Marios Detsis, Christos A Grigoras, et al.
Drugs
|
February 12, 2004
The role of proton pump inhibitors in gastro-oesophageal reflux disease
Roy Dekel, Chad Morse, Ronnie Fass
Drugs
|
November 2, 2004
Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system
André J Scheen
Page
of 708